Heterogeneous/JJ
expression/NN
of/IN
Epstein-Barr/JJ
virus/NN
latent/JJ
proteins/NNS
in/IN
endemic/JJ
Burkitt/NN
's/POS
lymphoma/NN
./.

Epstein-Barr/JJ
virus/NN
(/(
EBV/NN
)/)
-infected/JJ
cells/NNS
may/MD
sustain/VB
three/CD
distinct/JJ
forms/NNS
of/IN
virus/NN
latency/NN
./.
=====
In/IN
lymphoblastoid/JJ
cell/NN
lines/NNS
,/,
six/CD
EBV-encoded/JJ
nuclear/JJ
antigens/NNS
(/(
EBNA1/NN
,/,
2/CD
,/,
3A/NN
,/,
3B/NN
,/,
3C/NN
,/,
-LP/NN
)/)
,/,
three/CD
latent/JJ
membrane/NN
proteins/NNS
(/(
LMP1/NN
,/,
2A/NN
,/,
2B/NN
)/)
,/,
and/CC
two/CD
nuclear/JJ
RNAs/NNS
(/(
EBERs/NNS
)/)
are/VBP
expressed/VBN
./.
=====
This/DT
form/NN
of/IN
latency/NN
,/,
termed/VBN
latency/NN
III/CD
,/,
is/VBZ
also/RB
encountered/VBN
in/IN
some/DT
posttransplant/JJ
lymphoproliferative/JJ
disorders/NNS
./.
=====
In/IN
EBV-positive/JJ
cases/NNS
of/IN
Hodgkin/NN
's/POS
disease/NN
,/,
the/DT
EBERs/NNS
,/,
EBNA1/NN
,/,
and/CC
the/DT
LMPs/NNS
are/VBP
expressed/VBN
(/(
latency/NN
II/CD
)/)
,/,
whereas/IN
in/IN
Burkitt/NN
's/POS
lymphoma/NN
(/(
BL/NN
)/)
only/RB
the/DT
EBERs/NNS
and/CC
EBNA1/NN
have/VBP
been/VBN
detected/VBN
(/(
latency/NN
I/NN
)/)
./.
=====
We/PRP
have/VBP
studied/VBN
the/DT
expression/NN
of/IN
EBV/NN
proteins/NNS
in/IN
17/CD
cases/NNS
of/IN
EBV-positive/JJ
endemic/JJ
BL/NN
by/IN
immunohistology/NN
./.
=====
Expression/NN
of/IN
LMP1/NN
was/VBD
seen/VBN
in/IN
variable/JJ
proportions/NNS
of/IN
tumor/NN
cells/NNS
in/IN
two/CD
cases/NNS
and/CC
EBNA2/NN
was/VBD
detected/VBN
in/IN
some/DT
tumor/NN
cells/NNS
in/IN
three/CD
other/JJ
cases/NNS
./.
=====
Also/RB
,/,
the/DT
BZLF1/NN
trans-activator/NN
protein/NN
was/VBD
expressed/VBN
in/IN
a/DT
few/JJ
tumor/NN
cells/NNS
in/IN
6/CD
cases/NNS
,/,
indicating/VBG
entry/NN
into/IN
the/DT
lytic/JJ
cycle/NN
./.
=====
A/DT
phenotypic/JJ
drift/NN
from/IN
latency/NN
I/NN
to/TO
latency/NN
III/CD
has/VBZ
been/VBN
observed/VBN
previously/RB
in/IN
some/DT
BL/NN
cell/NN
lines/NNS
./.
=====
Our/PRP$
results/NNS
suggest/VBP
that/IN
a/DT
similar/JJ
phenomenon/NN
may/MD
occur/VB
in/IN
BL/NN
in/FW
vivo/FW
and/CC
indicate/VBP
that/IN
the/DT
operational/JJ
definition/NN
of/IN
EBV/NN
latencies/NNS
is/VBZ
not/RB
easily/RB
applied/VBN
to/TO
human/JJ
tumors/NNS
./.